Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia
Kjeld Schmiegelow(University of Copenhagen), Maria Grazia Valsecchi(University of Milano-Bicocca), Susana C. Raimondi(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), Keizo Horibe(National Hospital Organization), Franco Locatelli(Bambino Gesù Children's Hospital), Gabriele Escherich(Universität Hamburg), Naomi Winick(Universität Hamburg), Christiane Heydrich(Universität Hamburg), Rob Pieters(Princess Máxima Center), Lewis B. Silverman(Columbia University Irving Medical Center), Caroline Piette(Centre hospitalier régional de la Citadelle), Mette Levinsen(Universität Hamburg), Yasushi Ishida(Universität Hamburg), Meenakshi Devidas(National Institutes of Health), Andishe Attarbaschi(Cancer Research Institute of the Slovak Academy of Sciences), Gérard Michel(Hôpital d'Enfants), Der-Cherng Liang(Mackay Memorial Hospital), Brenda Gibson(Royal Hospital for Children), Martin Stanulla(Leibniz University Hannover), Batia Stark(Schneider Children's Medical Center), André Baruchel(Université Paris Cité)
Cited by 140
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914